Parmodia Tops November GP Rep Promotion List, Dayvigo HP Champion for 4th Month

January 18, 2024
Kowa’s hyperlipidemia treatment Parmodia (pemafibrate) became the most heavily pitched drug by sales reps for GPs by way of in person detailing in November, according to a monthly Intage survey. Intage’s “Impact Track” detailing track survey asks some 4,000 GPs/hospital...read more